Cyprumed Oral Delivery Technology Enters Clinical Stage With MSD
INNSBRUCK, Austria — September 29, 2026 Cyprumed GmbH announced that MSD has initiated a Phase 1 clinical trial of...
peptide therapeutics
Advertisement
Protagonist Therapeutics Wins FDA Approval for MIMRYLO
Protagonist Therapeutics, Newark, California, August 28, 2026 Protagonist Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
Samsung Biologics to Acquire PolyPeptide for CHF 1.46B
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
Vector Secures Exclusive cGMP Peptide Manufacturing Deal
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
InnoCare Doses First Patient in ICP-B208 ADC Clinical Trial
BEIJING, China, July 6, 2026 InnoCare Pharma has announced a significant milestone in its oncology pipeline with the first...
Advertisements
Ascletis Submits FDA INDs for Next-Generation Obesity Drugs
HONG KONG, July 6, 2026 Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...
Waters Launches New Platform for GLP-1 and LNP Analytics
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
Zealand Pharma Showcases Petrelintide Obesity Data
COPENHAGEN, Denmark, May 27, 2026 Zealand Pharma announced that new clinical data from its obesity and metabolic disease pipeline...
Sapience Reports Positive Glioblastoma Trial Data
TARRYTOWN, N.Y., May 21, 2026 Sapience Therapeutics has announced encouraging updated clinical data from its ongoing Phase 2 trial...
Merck Publishes Science Paper on Scalable Oral PCSK9 Inhibitor Manufacturing
RAHWAY, N.J., May 7, 2026 Merck announced the publication of a landmark scientific paper in the journal Science detailing...
Advertisement
